Correction to: Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies
- PDF / 141,795 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 46 Downloads / 189 Views
CORRECTION
Open Access
Correction to: Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies Elif Nurtop1*, Paola Mariela Saba Villarroel1,2, Boris Pastorino1, Laetitia Ninove1, Jan Felix Drexler3, Yelin Roca2, Bouba Gake1,4, Audrey Dubot-Peres1, Gilda Grard1,5, Christophe Peyrefitte1,5, Stéphane Priet1, Xavier de Lamballerie1 and Pierre Gallian1,6 Correction to: Virol J https://doi.org/10.1186/s12985-018-1105-5 In the original publication of this article [1], Table 1 has some errors. The correct one is below: Table 1 Comparison of VNT and PRNT assays for a panel of 142 samples VNT
PRNT50 Positive (titre ≥10)
PRNT90 Negative (titre < 10)
Positive (titre ≥10)
Negative (titre < 10)
Positive (titre ≥40)
51
1
51
1
Negative (titre < 40)
9
81
1
89
Sensitivity of VNT (95% CI)
85% (51/60) (72.9–92.4%)
98.8% (51/52) (88.4–99.9%)
Specificity of VNT (95% CI)
98.7% (81/82) (92.4–99.9%)
98.8% (89/90) (93.1–99.9%)
The publisher apologizes to the readers and authors for the inconvenience. The original publication has been corrected. Author details 1 Unité des Virus Émergents (UVE: Aix-Marseille Univ – IRD 190 – Inserm 1207– IHU Méditerranée Infection), Marseille, France. 2Virología II, Centro Nacional de Enfermedades Tropicales (CENETROP), Santa Cruz de la Sierra, Bolivia. 3Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany. 4Centre Pasteur du Cameroun, Yaoundé, Cameroon. 5National Reference Centre for Arboviruses, French Armed Forces Biomedical Research Institute, Marseille, France. 6Laboratoire de Virologie, Établissement Français du Sang Alpes Méditerranée (EFS), Marseille, France. Received: 4 January 2019 Accepted: 8 January 2019
Reference 1. Nurtop, et al. Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies. Virol J. 2018;15:192. https:// doi.org/10.1186/s12985-018-1105-5. * Correspondence: [email protected] 1 Unité des Virus Émergents (UVE: Aix-Marseille Univ – IRD 190 – Inserm 1207– IHU Méditerranée Infection), Marseille, France Full list of author information is available at the end of the article © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Data Loading...
